Drug recall
Gabapentin Tablets USP, 600 mg, 100 count bottle Rx only, Manufactured In Israel By: Teva Pharmaceutical…
FDA recall event 58611 · Class II · Teva Pharmaceuticals USA, Inc.
Key facts
| Event ID | 58611 |
|---|---|
| Recall numbers | D-745-2011 |
| Recalling firm | Teva Pharmaceuticals USA, Inc. |
| Product type | Drugs |
| Products | Gabapentin Tablets USP, 600 mg, 100 count bottle Rx only, Manufactured In Israel By: Teva Pharmaceutical Industries Ltd, Jerusalem, 91010, Israel. NDC 0093-4443-01 |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Presence of Foreign Substance: Potential for small glass particles |
| Initiation date | Apr 15, 2011 |
| Termination date | Sep 11, 2012 |
| City | Sellersville |
| State | PA |
| Country | United States |
| FEI number | 2517175 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports